- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x O7V: (2R)-2-[(3S,4R,5E,10E,12E,14S,16R,26aR)-16-fluoro-14-hydroxy-4,12-dimethyl-1,7,22-trioxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate(Non-covalent)
- 9 x CL: CHLORIDE ION(Non-functional Binders)
CL.2: 2 residues within 4Å:- Chain A: L.50, Y.51
Ligand excluded by PLIPCL.3: 5 residues within 4Å:- Chain A: P.3, D.4, N.7, P.10
- Chain C: M.95
Ligand excluded by PLIPCL.6: 1 residues within 4Å:- Chain B: Y.51
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain B: F.167, S.168, V.171
Ligand excluded by PLIPCL.8: 5 residues within 4Å:- Chain B: L.9, P.10, I.11, N.14, L.17
Ligand excluded by PLIPCL.9: 7 residues within 4Å:- Chain A: N.158
- Chain B: A.140, A.141, E.142, A.143, G.156, G.157
Ligand excluded by PLIPCL.13: 1 residues within 4Å:- Chain C: Y.51
Ligand excluded by PLIPCL.14: 7 residues within 4Å:- Chain A: I.196
- Chain C: R.82, M.83, D.84, G.85, S.86, T.87
Ligand excluded by PLIPCL.15: 6 residues within 4Å:- Chain C: Y.152, W.175, L.178, Q.179, W.180, W.181
Ligand excluded by PLIP- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 3 x SXA: THIOACETIC ACID S-{2-[3-(2-HYDROXY-3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)-PROPIONYLAMINO]-ETHYL} ESTER(Non-covalent)
SXA.11: 24 residues within 4Å:- Chain A: Y.51, I.75, A.79, N.80, H.81, M.83, K.110, M.128
- Chain B: Y.36, S.67, I.68, G.69, P.70, W.120, I.121, G.122, R.123, I.138, A.140, A.141, I.154, I.163, R.164
- Ligands: O7V.1
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.154
- Hydrogen bonds: B:A.141, A:H.81
SXA.16: 26 residues within 4Å:- Chain B: Y.51, I.75, A.79, N.80, H.81, M.83, P.108, K.110, M.128, P.129
- Chain C: Y.36, S.67, I.68, G.69, P.70, W.120, I.121, G.122, R.123, I.138, I.139, A.140, A.141, I.154, R.164
- Ligands: O7V.5
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain C- Hydrogen bonds: B:A.79, B:H.81, C:W.120, C:A.141
- Hydrophobic interactions: C:W.120
SXA.17: 21 residues within 4Å:- Chain A: S.67, G.69, P.70, W.120, I.121, G.122, R.123, I.138, A.140, A.141, I.154, I.163, R.164
- Chain C: Y.51, I.75, A.79, N.80, H.81, M.83, K.110
- Ligands: O7V.12
5 PLIP interactions:1 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: C:K.110, A:A.141
- Hydrophobic interactions: A:W.120, A:I.154, A:I.163
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Q. et al., Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature (2020)
- Release Date
- 2020-11-18
- Peptides
- Virginiamycin A acetyltransferase,VatA: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
EC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x O7V: (2R)-2-[(3S,4R,5E,10E,12E,14S,16R,26aR)-16-fluoro-14-hydroxy-4,12-dimethyl-1,7,22-trioxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate(Non-covalent)
- 9 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 3 x SXA: THIOACETIC ACID S-{2-[3-(2-HYDROXY-3,3-DIMETHYL-4-PHOSPHONOOXY-BUTYRYLAMINO)-PROPIONYLAMINO]-ETHYL} ESTER(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Q. et al., Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature (2020)
- Release Date
- 2020-11-18
- Peptides
- Virginiamycin A acetyltransferase,VatA: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
EC
F